127 related articles for article (PubMed ID: 33361582)
1. MiR-3666 serves as a tumor suppressor in ovarian carcinoma by down-regulating AK4 via targeting STAT3.
Tan H; Wu C; Huang B; Jin L; Jiang X
Cancer Biomark; 2021; 30(4):355-363. PubMed ID: 33361582
[TBL] [Abstract][Full Text] [Related]
2. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
[TBL] [Abstract][Full Text] [Related]
3. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
4. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
[TBL] [Abstract][Full Text] [Related]
5. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-204-5p Inhibits Ovarian Cancer Cell Proliferation by Down-Regulating USP47.
Hu L; Kolibaba H; Zhang S; Cao M; Niu H; Mei H; Hao Y; Xu Y; Yin Q
Cell Transplant; 2019 Dec; 28(1_suppl):51S-58S. PubMed ID: 31526052
[TBL] [Abstract][Full Text] [Related]
7. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
Qiao B; Wang Q; Zhao Y; Wu J
Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
Qu C; Dai C; Guo Y; Qin R; Liu J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
[TBL] [Abstract][Full Text] [Related]
9. miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3.
Li Y; Zhang Z; Liu X; Huang T; He W; Shen Y; Liu X; Hong K; Cao Q
Mol Cell Biochem; 2014 Mar; 388(1-2):219-31. PubMed ID: 24287565
[TBL] [Abstract][Full Text] [Related]
10. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
12. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
Liu B; Zhang J; Yang D
J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
[TBL] [Abstract][Full Text] [Related]
13. MiR-10a-5p restrains the aggressive phenotypes of ovarian cancer cells by inhibiting HOXA1.
Liu LJ; Sun XY; Yang CX; Zou XY
Kaohsiung J Med Sci; 2021 Apr; 37(4):276-285. PubMed ID: 33332731
[TBL] [Abstract][Full Text] [Related]
14. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
15. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
[TBL] [Abstract][Full Text] [Related]
16. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Jiang HW; Li L; Jiang P; Wang YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.
Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis.
Wu Z; Gong Q; Yu Y; Zhu J; Li W
BMC Pulm Med; 2020 Jan; 20(1):10. PubMed ID: 31931771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
